![Hugh Wight](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hugh Wight
Technik-/Wissenschafts-/F&E-Leiter bei
ALLENA PHARMACEUTICALS, INC.
Profil
Hugh Wight is currently the Senior Vice President-Technical Operations at Allena Pharmaceuticals, Inc. He previously worked as the Director-Quality Systems at Alkermes, Inc., Senior Director-Quality at Altus Pharmaceuticals, Inc., Principal at InSite Vision, Inc., Principal at AutoImmune, Inc., and Principal at Aquila Biopharmaceuticals, Inc. From 2010 to 2012, he served as the Vice President-Technical Operations at Alnara Pharmaceuticals, Inc. He also held the position of Vice President-Technical Operations at Alcresta Therapeutics, Inc. Mr. Wight obtained his undergraduate degree from the University of Maine in 1987.
Aktive Positionen von Hugh Wight
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Hugh Wight
| Unternehmen | Position | Ende |
|---|---|---|
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of metabolic diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2012 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Aquila Biopharmaceuticals, Inc.
 Aquila Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops and makes products for the diagnosis, prevention and treatment of infectious diseases | Corporate Officer/Principal | - |
| INSITE VISION INC. | Corporate Officer/Principal | - |
AutoImmune, Inc.
 AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Corporate Officer/Principal | - |
Ausbildung von Hugh Wight
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
Aquila Biopharmaceuticals, Inc.
Aquila Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops and makes products for the diagnosis, prevention and treatment of infectious diseases | Health Technology |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of metabolic diseases | Health Technology |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
Allena Pharmaceuticals, Inc.
 Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online | Health Technology |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
